Zevra Therapeutics Inc (ZVRA)
$10.28 -0.77% Close Oct 30, 2026 Live
Zevra Therapeutics stock today
Zevra Therapeutics closed at $10.28 on October 30, 2026, down 0.77% on the day. Over the past year it returned +1.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $608 million.
$8.00$10.00$12.00$14.00
NovJan 2026MarMayJulSep
| Period | ZVRA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -6.3% | -0.9% |
| 3 months | +6.6% | +2.1% |
| Year to date | +14.7% | +11.7% |
| 1 year | +1.4% | +12.4% |
| 3 years | +137.4% | +88.5% |
| 5 years | +8.2% | +76.0% |
Key statistics
- Market value
- $608M
- P/E (trailing)
- 10.9
- Forward P/E
- 9.2
- Price / sales
- 4.5
- 52-week range
- $8.10 to $14.75
- Next report
- Nov 3, 2026
About Zevra Therapeutics
Biopharmaceutical company developing treatments for rare genetic diseases.
Sector: Health Care
More on Zevra Therapeutics
- Financials: revenue, earnings and segmentsRevenue +351% in the year to Dec 2025
- Valuation: P/E history and peersP/E 10.9
- Returns: what $1,000 became$1,000 ten years ago is $169.08 today
No forecast, no recommendation. This page describes Zevra Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.